CANMAb™
Brand Name: CANMAb™
Composition: Trastuzumab (r-DNA origin), strength 440 mg
Product Description
Medical Info
CANMAb™ (Trastuzumab) is a prescription medicine, manufactured by Biocon, for use as an intravenous infusion to treat HER2-positive breast and gastric cancers. It is classified as a monoclonal antibody that targets the HER2 protein on cancer cell surfaces, slowing their growth and spread. As shown in image_24.png, it is a combination pack that includes a 440 mg multi-dose vial of Trastuzumab lyophilized powder and two vials of Bacteriostatic Water for Injection USP, which serves as a diluent. This sterile, preservative-free medication must be administered under the direct supervision of a healthcare professional in a controlled clinical setting.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
